Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? (Q38085592)

28 August 2017

Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? (English)

1 reference

28 August 2017

0 references

1 reference

cognitive dysfunction

1 reference

3

1 reference

28 August 2017

Michael J Firbank

2

0 references

David Burn

object named as

David J Burn

series ordinal

4

0 references

author name string

Gordon W Duncan

series ordinal

1

1 reference

PubMed ID

23450518

28 August 2017

language of work or name

English

0 references

publication date

28 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

28

1 reference

28 August 2017

425-438

1 reference

28 August 2017

4

1 reference

Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability.

28 August 2017

1 reference

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

21 January 2018

1 reference

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

21 January 2018

1 reference

Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

21 January 2018

1 reference

Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia.

21 January 2018

1 reference

Grey and white matter changes at different stages of Alzheimer's disease.

21 January 2018

1 reference

MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study

21 January 2018

1 reference

Predicting MCI outcome with clinically available MRI and CSF biomarkers

21 January 2018

1 reference

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials

21 January 2018

1 reference

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

21 January 2018

1 reference

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

Stages in the development of Parkinson's disease-related pathology

21 January 2018

1 reference

Cognitive status correlates with neuropathologic stage in Parkinson disease.

21 January 2018

1 reference

The progression of pathology in longitudinally followed patients with Parkinson's disease.

21 January 2018

1 reference

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.

21 January 2018

1 reference

Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease.

21 January 2018

1 reference

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

Cholinergic dysfunction in diseases with Lewy bodies.

21 January 2018

1 reference

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.

21 January 2018

1 reference

The pedunculopontine nucleus and Parkinson's disease

21 January 2018

1 reference

Cholinergic interneuron characteristics and nicotinic properties in the striatum

21 January 2018

1 reference

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease

21 January 2018

1 reference

MRI and cognitive impairment in Parkinson's disease

21 January 2018

1 reference

Functional and anatomical magnetic resonance imaging in Parkinson's disease

21 January 2018

1 reference

Validation of a fully automated hippocampal segmentation method on patients with dementia.

21 January 2018

1 reference

Application of automated medial temporal lobe atrophy scale to Alzheimer disease.

21 January 2018

1 reference

A voxel-based morphometric study of ageing in 465 normal adult human brains

21 January 2018

1 reference

Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias

21 January 2018

1 reference

Neurodegeneration across stages of cognitive decline in Parkinson disease

21 January 2018

1 reference

Computational anatomy with the SPM software

21 January 2018

1 reference

A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging

21 January 2018

1 reference

Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment.

21 January 2018

1 reference

Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area

21 January 2018

1 reference

Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness.

21 January 2018

1 reference

Functional impact of white matter hyperintensities in cognitively normal elderly subjects

21 January 2018

1 reference

Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study

21 January 2018

1 reference

White matter lesions in Parkinson disease

21 January 2018

1 reference

Cognitive impact of subcortical vascular and Alzheimer's disease pathology

21 January 2018

1 reference

Anisotropy in diffusion-weighted MRI.

21 January 2018

1 reference

Diffusion-tensor MR imaging and tractography: exploring brain microstructure and connectivity.

21 January 2018

1 reference

Diffusion tensor imaging and cognitive function in older adults with no dementia

21 January 2018

1 reference

Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease.

21 January 2018

1 reference

Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications

21 January 2018

1 reference

Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease

21 January 2018

1 reference

Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

21 January 2018

1 reference

Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

Cerebral atrophy and its relation to cognitive impairment in Parkinson disease.

21 January 2018

1 reference

Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study.

21 January 2018

1 reference

A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry

21 January 2018

1 reference

The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status.

21 January 2018

1 reference

Cognitive status correlates with white matter alteration in Parkinson's disease.

21 January 2018

1 reference

Grey matter atrophy in cognitively impaired Parkinson's disease.

21 January 2018

1 reference

Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

21 January 2018

1 reference

Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia

21 January 2018

1 reference

Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.

21 January 2018

1 reference

Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

21 January 2018

1 reference

Parkinson's disease is associated with hippocampal atrophy.

21 January 2018

1 reference

Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia.

21 January 2018

1 reference

Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia.

21 January 2018

1 reference

Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia

21 January 2018

1 reference

A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with lewy bodies. A comparison with Alzheimer's disease and Parkinson's disease with and without dementia.

21 January 2018

1 reference

Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease.

21 January 2018

1 reference

MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

Altered diffusion in the frontal lobe in Parkinson disease

21 January 2018

1 reference

Gray matter correlations of cognition in incident Parkinson's disease.

21 January 2018

1 reference

Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia.

21 January 2018

1 reference

Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.

21 January 2018

1 reference

Temporal lobe changes in early, untreated Parkinson's disease.

21 January 2018

1 reference

Focal cortical and subcortical atrophy in early Parkinson's disease

21 January 2018

1 reference

Patterns of cortical thickness and surface area in early Parkinson's disease

21 January 2018

1 reference

Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease

21 January 2018

1 reference

Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment

21 January 2018

1 reference

Ventricular enlargement and mild cognitive impairment in early Parkinson's disease

21 January 2018

1 reference

Acetylcholine in mind: a neurotransmitter correlate of consciousness?

21 January 2018

1 reference

Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

Substantia innominata: MR findings in Parkinson's disease.

21 January 2018

1 reference

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

21 January 2018

1 reference

Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging.

21 January 2018

1 reference

Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.

21 January 2018

1 reference

Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.

21 January 2018

1 reference

Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia.

21 January 2018

1 reference

Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations

21 January 2018

1 reference

Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease

21 January 2018

1 reference

Visual rating of white matter hyperintensities in Parkinson's disease.

21 January 2018

1 reference

Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging

21 January 2018

1 reference

White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.

21 January 2018

1 reference

Wisconsin Card Sorting Test in Parkinson's disease: diffusion tensor imaging

21 January 2018

1 reference

Case control study of diffusion tensor imaging in Parkinson's disease.

21 January 2018

1 reference

Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI.

21 January 2018

1 reference

White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study.

21 January 2018

1 reference

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

21 January 2018

1 reference

Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease.

21 January 2018

1 reference

Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson's disease

21 January 2018

1 reference

Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study.

21 January 2018

1 reference

Dysfunctions of cerebral networks precede recognition memory deficits in early Parkinson's disease.

21 January 2018

1 reference

Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype

21 January 2018

1 reference

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease.

21 January 2018

1 reference

Cortical activity in Parkinson's disease during executive processing depends on striatal involvement

21 January 2018

1 reference

Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition

21 January 2018

1 reference

Dopaminergic modulation of cortical function in patients with Parkinson's disease

21 January 2018

1 reference

Altered cortical visual processing in PD with hallucinations: an fMRI study

21 January 2018

1 reference

Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.

21 January 2018

1 reference

Dementia in Parkinson disease: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease.

21 January 2018

1 reference

Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia

21 January 2018

1 reference

Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study

21 January 2018

1 reference

Regional cerebral blood flow in Parkinson's disease with and without dementia.

21 January 2018

1 reference

Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study

21 January 2018

1 reference

Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease

21 January 2018

1 reference

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

21 January 2018

1 reference

Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia.

21 January 2018

1 reference

Association of gait and balance disorders with age-related white matter changes: The LADIS Study

21 January 2018

1 reference

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

21 January 2018

1 reference

Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.25352

1 reference

28 August 2017

1 reference

PubMed ID

23450518